Medadvisor Ltd
ASX:MDR

Watchlist Manager
Medadvisor Ltd Logo
Medadvisor Ltd
ASX:MDR
Watchlist
Price: 0.022 AUD -8.33% Market Closed
Market Cap: 13.9m AUD
Section:
 

Relative Value

The Relative Value of one MDR stock under the Base Case scenario is 0.228 AUD. Compared to the current market price of 0.022 AUD, Medadvisor Ltd is Undervalued by 90%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDR Relative Value
Base Case
0.228 AUD
Undervaluation 90%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
98
vs Industry
76
Median 3Y
1
Median 5Y
1.2
Industry
2.3
Forward
0.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-9
Median 5Y
-9.2
Industry
22.4
Forward
5.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
42
Median 3Y
-4.2
Median 5Y
-10.5
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
35
Median 3Y
-5.5
Median 5Y
-14.9
Industry
21.5
More Details
13.1
P/B
P/B
Price to Book Value
13.1
vs History
7
vs Industry
62
Median 3Y
2.6
Median 5Y
2.6
Industry
2.2
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
98
vs Industry
76
Median 3Y
1
Median 5Y
1.2
Industry
2.5
Forward
0.2
More Details
0.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.6
vs History
98
vs Industry
81
Median 3Y
1.8
Median 5Y
2
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-17.9
Median 5Y
-9.4
Industry
12
Forward
1.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-17.9
Median 5Y
-9.4
Industry
17.1
Forward
2.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
44
Median 3Y
-4.7
Median 5Y
-10.2
Industry
14.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
37
Median 3Y
-4.2
Median 5Y
-9.6
Industry
18.8
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
92
vs Industry
61
Median 3Y
1.5
Median 5Y
1.5
Industry
1.8
More Details

Multiples Across Competitors

MDR Competitors Multiples
Medadvisor Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Medadvisor Ltd
ASX:MDR
13.7m AUD 0.2 -0.2 -1.6 -1.6
US
Veeva Systems Inc
NYSE:VEEV
36.2B USD 11.7 42 31.8 33.2
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
23.6B AUD 107.1 205 141.6 141.6
JP
M3 Inc
TSE:2413
1.4T JPY 4.2 30.1 15.7 19.3
US
Doximity Inc
NYSE:DOCS
8.4B USD 13.5 33.2 29.1 30.5
US
Waystar Holding Corp
NASDAQ:WAY
5.7B USD 5.5 51.2 17 26.7
SE
Sectra AB
STO:SECT B
49.4B SEK 23.1 84.3 -118.3 -118.3
US
Inspire Medical Systems Inc
NYSE:INSP
3.5B USD 3.9 77.8 63.7 85.6
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
285.9B INR 10.7 58.8 36.6 42.7
US
Vocera Communications Inc
F:V00
2.4B EUR 12 -332.2 271.4 4 345.6
P/E Multiple
Earnings Growth PEG
AU
Medadvisor Ltd
ASX:MDR
Average P/E: 70.6
Negative Multiple: -0.2 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
42
32%
1.3
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
205
32%
6.4
JP
M3 Inc
TSE:2413
30.1
16%
1.9
US
Doximity Inc
NYSE:DOCS
33.2
18%
1.8
US
W
Waystar Holding Corp
NASDAQ:WAY
51.2
N/A N/A
SE
Sectra AB
STO:SECT B
84.3
28%
3
US
Inspire Medical Systems Inc
NYSE:INSP
77.8
13%
6
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
58.8
30%
2
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -332.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Medadvisor Ltd
ASX:MDR
Average EV/EBITDA: 69.9
Negative Multiple: -1.6 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
31.8
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
141.6
32%
4.4
JP
M3 Inc
TSE:2413
15.7
14%
1.1
US
Doximity Inc
NYSE:DOCS
29.1
23%
1.3
US
W
Waystar Holding Corp
NASDAQ:WAY
17
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -118.3 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
63.7
80%
0.8
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
36.6
24%
1.5
US
V
Vocera Communications Inc
F:V00
271.4
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Medadvisor Ltd
ASX:MDR
Average EV/EBIT: 529.8
Negative Multiple: -1.6 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33.2
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
141.6
31%
4.6
JP
M3 Inc
TSE:2413
19.3
N/A N/A
US
Doximity Inc
NYSE:DOCS
30.5
25%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
26.7
56%
0.5
SE
Sectra AB
STO:SECT B
Negative Multiple: -118.3 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
85.6
34%
2.5
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
42.7
27%
1.6
US
V
Vocera Communications Inc
F:V00
4 345.6
N/A N/A

See Also

Summary
MDR intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDR stock valuation using valuation multiples.
Wall Street Estimates
MDR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.